Cargando…

Roles of the Metabolic Syndrome, HDL Cholesterol, and Coronary Atherosclerosis in Subclinical Inflammation

OBJECTIVE: The metabolic syndrome (MetS) and coronary artery disease (CAD) frequently coincide; their individual contribution to inflammation is unknown. RESEARCH DESIGN AND METHODS: We enrolled 1,010 patients undergoing coronary angiography. Coronary stenoses ≥50% were considered significant. The M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rein, Philipp, Saely, Christoph H., Beer, Stefan, Vonbank, Alexander, Drexel, Heinz
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909077/ https://www.ncbi.nlm.nih.gov/pubmed/20484132 http://dx.doi.org/10.2337/dc09-2376

Ejemplares similares

Single Nucleotide Polymorphisms of TCF7L2 Are Linked to Diabetic Coronary Atherosclerosis
por: Muendlein, Axel, et al.
Publicado: (2011)

Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease
por: Vonbank, Alexander, et al.
Publicado: (2013)

Coronary patients with high plasma omentin are at a higher cardiovascular risk
por: Saely, Christoph H., et al.
Publicado: (2015)

Genome-Wide Association Study Reveals a Polymorphism in the Podocyte Receptor RANK for the Decline of Renal Function in Coronary Patients
por: Leiherer, Andreas, et al.
Publicado: (2014)

Downhill hiking improves low-grade inflammation, triglycerides, body weight and glucose tolerance
por: Drexel, Heinz, et al.
Publicado: (2021)

Bile Acid Metabolites in Serum: Intraindividual Variation and Associations with Coronary Heart Disease, Metabolic Syndrome and Diabetes Mellitus
por: Steiner, Carine, et al.
Publicado: (2011)

Toward a more professional and practical medical education: a novel Central European approach
por: Drexel, Heinz, et al.
Publicado: (2015)

Data on the association between CTRP1 and future major adverse cardiovascular events in patients undergoing coronary angiography
por: Muendlein, Axel, et al.
Publicado: (2019)

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
por: Tejera-Segura, Beatriz, et al.
Publicado: (2017)

HDL Size is More Accurate than HDL Cholesterol to Predict Carotid Subclinical Atherosclerosis in Individuals Classified as Low Cardiovascular Risk
por: Parra, Eliane Soler, et al.
Publicado: (2014)

Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
por: Sprenger, Lukas, et al.
Publicado: (2021)

Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitus
por: Othman, Alaa, et al.
Publicado: (2015)

Value of total cholesterol readings earlier versus later in life to predict cardiovascular risk
por: Leiherer, Andreas, et al.
Publicado: (2021)

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
por: Fadaei, Reza, et al.
Publicado: (2018)

Are SGLT2 polymorphisms linked to diabetes mellitus and cardiovascular disease? Prospective study and meta-analysis
por: Drexel, Heinz, et al.
Publicado: (2019)

Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease
por: Hancock-Cerutti, William, et al.
Publicado: (2021)

Data on the impact of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events
por: Saely, Christoph H., et al.
Publicado: (2018)

HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2021)

Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level
por: Paavola, Timo, et al.
Publicado: (2017)

Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
por: Srivastava, Neelam, et al.
Publicado: (2018)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Single and joint impact of type 2 diabetes and of congestive heart failure on albuminuria: Data from subgroup analysis and data on moderate albuminuria
por: Saely, Christoph H., et al.
Publicado: (2022)

HDL cholesterol is associated with PBMC expression of genes involved in HDL metabolism and atherogenesis
por: Dergunova, Liudmila V., et al.
Publicado: (2020)

Triglyceride/HDL-Cholesterol Ratio as an Index of Intracranial Atherosclerosis in Nonstroke Individuals
por: Woo, Min-Hee, et al.
Publicado: (2021)

Cholesterol and Inflammation in Atherosclerosis: An Immune-Metabolic Hypothesis
por: Mauricio, Didac, et al.
Publicado: (2020)

HDL Subclass Analysis in Predicting Metabolic Syndrome in Koreans With High HDL Cholesterol Levels
por: Yang, Hyun Suk, et al.
Publicado: (2020)

Metabolic syndrome criteria as predictors of subclinical atherosclerosis based on the coronary calcium score
por: Seo, Mi Hae, et al.
Publicado: (2015)

Data on the power of the creatinine to uromodulin ratio in serum to predict cardiovascular events in coronary patients
por: Leiherer, Andreas, et al.
Publicado: (2017)

Subclinical Hyperthyroidism: Status of the Cholesterol Transfers to HDL and Other Parameters Related to Lipoprotein Metabolism in Patients Submitted to Thyroidectomy for Thyroid Cancer
por: Sigal, Gilbert A., et al.
Publicado: (2020)

HDL signaling and protection against coronary artery atherosclerosis in mice
por: Trigatti, Bernardo L, et al.
Publicado: (2016)

Serum uromodulin is associated with impaired glucose metabolism
por: Leiherer, Andreas, et al.
Publicado: (2017)

Variability of the Plasma Lipidome and Subclinical Coronary Atherosclerosis
por: Tan, Sock Hwee, et al.
Publicado: (2021)

Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol–related inflammatory parameters as predictors
por: Guo, Xuantong, et al.
Publicado: (2022)

Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis
por: Zhou, Mei, et al.
Publicado: (2019)

HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease
por: Meikle, Peter J., et al.
Publicado: (2019)

Subclinical Atherosclerosis in Primary Sjögren's Syndrome: Does Inflammation Matter?
por: Bartoloni, Elena, et al.
Publicado: (2019)

HDL Cholesterol Story Is Dead: Long Live HDL!
por: Simha, Vinaya, et al.
Publicado: (2016)

Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
por: Bergström, Göran, et al.
Publicado: (2021)

Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis
por: Wang, Dianhui, et al.
Publicado: (2018)

Levels of Cholesterol in Small LDL Particles Predict Atherosclerosis Progression and Incident CHD in the HDL-Atherosclerosis Treatment Study (HATS)
por: Williams, Paul T., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7gp24do1c6qkupff5113ehe7gm